Trial intelligence / Profile preview

Envarsus XR in Adolescent Renal Transplant Recipients

NCT03266393Phase 4Active, not recruiting

Sponsor
University of California, Los Angeles
Start
Jan 2019
Primary completion
Mar 2023
Modality
RNA-Targeting Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tacrolimus in kidney transplantation, sponsored by University of California, Los Angeles. Started Jan 2019; status: active, not recruiting.

02

Drugs

tacrolimus
03

Conditions

kidney transplantation

Beyond the preview

Go deeper on NCT03266393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03266393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call